# An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation

> **NCT01336647** · PHASE2 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 142 (actual)

## Conditions studied

- Pediculosis

## Interventions

- **DRUG:** Group A - Low-Dose Ha44 0.37% w/w
- **DRUG:** Group B - High Dose Ha44 Gel 0.74% w/w
- **DRUG:** Group C - Placebo

## Key facts

- **NCT ID:** NCT01336647
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-08
- **Final completion:** 2012-03
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2020-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01336647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01336647, "An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01336647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*